logo

For the Inventor, By the Inventor

Loveland, OH, United States of America

David R Borcherding

This inventor holds 23 USPTO granted patents, plus 10 CIPO patents, primarily in Immunosuppressive Agents. Top assignees: Hoechst Marion Roussel, Aventis Pharmaceuticals Inc., Marion Merrell Dow Inc.. Active years: 1993-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David R Borcherding. Retrieved from https://idiyas.com/inventor/david-r-borcherding

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23

% Patents Active = 95.7

 

Average Co-Inventor Count = 3.9

ph-index = 4

Forward Citations = 130(Granted Patents)


Location History:

  • Overland, KS (US) (1995)
  • Overland Park, KS (US) (1993 - 1997)
  • Loveland, OH (US) (1995 - 2002)
  • Bangor, PA (US) (2002 - 2009)

Company Filing History:

goldMedal9 out of 236 
 
Hoechst Marion Roussel
 patents
silverMedal7 out of 207 
 
Aventis Pharmaceuticals Inc.
 patents
bronzeMedal2 out of 12 
 
Marion Merrell Dow Inc.
 patents
4. 2 out of 455 
 
Merrell Dow Pharmaceuticals
 patents
5. 2 out of 194 
 
Merrell Pharmaceuticals, Inc.
 patents
6. 1 out of 834,513 
Other
 patents

Years Active: 1993-2009

Loading Chart...
Loading Chart...
Areas of Expertise:
Immunosuppressants
Cytokine Inhibitors
Carbocyclic Nucleosides
Purine Analogs
Adenosine Derivatives
Antiproliferative Agents
Trans Cyclopentanyl
Bicyclic Nucleosides
23 patents (USPTO):Explore Patents
1. 7541368 - Pyrazoles as inhibitors of tumor necrosis factor (2009-06-02),
2. 7429595 - Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents (2008-09-30),
3. 6861524 - Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents (2005-03-01),
4. 6642231 - 6,9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines (2003-11-04),
5. 6541482 - Carbocyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines (2003-04-01),
6. 6479487 - 6, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines (2002-11-12),
7. 6436947 - Trans cyclopentanyl purine analogs useful as immunosuppressants (2002-08-20),
8. 6420373 - 9-N-Bicyclic nuceoside agents useful as selective inhibitors of proinflammatory cytokines (2002-07-16),
9. 6413974 - 6,9,-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines (2002-07-02),
10. 5929079 - Trans cyclopentanyl azaadenyl analogs useful as immunosuppressants (1999-07-27),
11. 5916892 - Trans cyclopentanyl deazaadenyl analogs useful as immunosuppressants (1999-06-29),
12. 5905085 - Trans cyclopentanyl deazaadenyl analogs useful as immunosuppressants (1999-05-18),
13. 5817672 - Trans cyclopentanyl purine analogs useful as immunosuppressants (1998-10-06),
14. 5817661 - Trans cyclopentanyl purine analogs useful as immunosuppressants (1998-10-06),
15. 5817660 - Trans cyclopentanyl purine analogs useful as immunosuppressants (1998-10-06),

Title: The Innovative Journey of David R Borcherding

Introduction:

David R Borcherding, a talented inventor hailing from Loveland, Ohio, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents:

David R Borcherding holds several patents in various technological domains, showcasing his versatility and creativity in inventing new solutions to complex problems.

Career Highlights:

With a career spanning over two decades, David R Borcherding has consistently pushed the boundaries of innovation. His work has been recognized for its ingenuity and practicality, earning him a reputation as a visionary in the industry.

Collaborations:

Throughout his career, David R Borcherding has collaborated with leading tech companies and research institutions to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion:

In conclusion, David R Borcherding's passion for innovation and his dedication to creating impactful solutions have solidified his position as a respected inventor in the technological landscape. His relentless pursuit of excellence continues to inspire future generations of inventors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…